-
AbbVie Inc. (ABBV $206.69)
-
Johnson & Johnson (JNJ $176.64)
-
Medtronic plc. (MDT $93.02)
-
Merck & Company Inc. (MRK $84.21)
Q: Is Merk unjustifiably cheap or is it a value trap? Which of MRK, JNJ, MDT (or other suggestion) would you recommend as a buy and forget cornerstone healthcare holding for someone looking for long term capital appreciation and dividend growth. My only other healthcare position is ABBV. Please also explain the rationale. Thank you!